The cleavage of parathyroid hormone (PTH) from its precursor proparathyroid hormone (pro-PTH) is accomplished efficiently by the proprotein convertase furin (Hendy, G. N., Bennett, H. P. J., Gibbs, B. F., Lazure, C., Day, R., and Seidah, N. G. (1995) J. Biol. Chem. 270, 9517-9525). We also showed that a synthetic peptide comprising the ؊6 to ؉7 sequence of human pro-PTH is appropriately cleaved by purified furin in vitro. The human pro-PTH processing site Lys-Ser-Val-Lys-LysArg differs from the consensus furin site Arg-Xaa-(Lys/ Arg)-Arg that is represented by Arg-Arg-Leu-Lys-Arg in the cleavage site of pro-PTH-related peptide (proPTHrP). An earlier study demonstrated that an internally quenched fluorogenic substrate bearing an O-aminobenzoyl fluorescent donor at the NH 2 terminus and an acceptor 3-nitrotyrosine near the COOH terminus was appropriately cleaved by the convertases furin and PC1 (Jean, F., Basak, A., DiMaio, J., Seidah, N. G., and Lazure, C. (1995) Biochem. J. 307, 689 -695). Here, we have synthesized a series of internally quenched fluorogenic substrates based upon the pro-PTH and pro-PTHrP sequences to determine which residues are important for furin cleavage. Purified recombinant furin and PC1 cleaved the human pro-PTH internally quenched substrate at the appropriate site in an identical manner to that observed with the nonfluorescent peptide. Several substitutions in the P 6 -P 3 sequence were well tolerated; however, replacement of the Lys at the P 6 position with Gly and replacement of the P 3 Lys by an acidic residue led to markedly compromised cleavage by furin. Furin activity was very sensitive to substitution in P positions. Replacement of Ser at P 1 with Gly and Val at P 2 with Ala generated substrates that were less well cleaved. Substitution at the P 1 position of Val for Ser in conjunction with Ala for Val at P 2 , as well as a single substitution of Lys for Val at P 2 , generated specific inhibitors of furin cleavage. The findings of this study open the way to the rational design of inhibitors of furin with therapeutic potential.
bearing a regulated secretory pathway, the most efficient processing was obtained with furin (14) . Additionally, whereas furin is expressed in the parathyroid cell, PC1 and PC2 are not (14, 15) .
In the vast majority of proproteins cleaved by furin, the processing site is of the consensus Arg-Xaa-(Arg/Lys)-Arg (P 4 -P 1 ) 3 (17) (18) (19) . However, in some cases, a sequence with two out of three basic residues at P 6 , P 4 , or P 2 , in addition to the P 1 Arg, or even Arg-Xaa-Xaa-Arg can constitute a competent furin site (20, 21) . The human pro-PTH processing site Lys-Ser-Val-LysLys-Arg (P 6 -P 1 ) corresponds to one of the less commonly found sites, whereas the pro-PTHrP processing site Arg-Arg-Leu-LysArg (P 5 -P 1 ) conforms to the typical furin site, and its processing to PTHrP is thought to be mediated by this proprotein convertase (22) . We have shown previously that a synthetic tridecapeptide corresponding to the Ϫ6 to ϩ7 sequence of human pro-PTH was efficiently cleaved at the appropriate site carboxyl-terminal to the -(P 2 )Lys-(P 1 )Arg sequence by purified furin in vitro (14) . Furthermore, we showed that an internally quenched fluorogenic substrate incorporating the proprotein cleavage site of the PC1 enzyme was a useful substrate to study convertase enzymatic activity (23) . In the present study we synthesized an internally quenched fluorogenic substrate based upon the pro-PTH (Ϫ6 to ϩ7) sequence bearing an Oaminobenzoyl fluorescent donor at the amino terminus and quenching 3-nitrotyrosine acceptor toward the carboxyl terminus. Having established this was appropriately cleaved by furin, we synthesized a series of similar substrates based upon the furin processing sites of both pro-PTH and pro-PTHrP to determine which residues are important for furin activity.
EXPERIMENTAL PROCEDURES
Materials-For fluorometric assays, the pentapeptide ϽGlu-ArgThr-Lys-Arg-MCA was obtained from Peptides International (Louisville, KY). The Fmoc-O-N-succinimide and the preloaded Fmoc-Ser-4-hydroxymethylphenoxy resin were purchased from Novabiochem (La Jolla, CA), and the Boc-anthranilic acid and (3-nitro)-Tyr were obtained from Bachem California (Torrance, CA) and Aldrich, respectively. The Fmoc-(3-nitro)-Tyr derivative was prepared as described (23) , and its identity was confirmed by fast atom bombardment mass spectroscopy and 1 H NMR. The endoprotease hfurin was obtained from conditioned medium of somatomammotroph GH 4 C 1 cells infected with recombinant vaccinia virus bearing hfurin as described (14, 24) and was partially purified by anion exchange chromatography yielding a single immunoreactive band upon SDS-polyacrylamide gel electrophoresis and a single electrophoretic band after labeling with an octapeptidyl chloromethylketone inhibitor (24) . Enzymatic activity was determined by a fluorometric assay using the substrate ϽGlu-Arg-Thr-Lys-Arg-MCA (24) . Recombinant murine PC1 was obtained from the medium of Sf9 insect cells infected with baculovirus vector bearing murine PC1 and purified by ammonium sulfate precipitation. 4 This preparation contains two unique immunoreactive bands after SDS-PAGE which correspond to the full-length murine PC1 (87 kDa) and a COOH-terminal truncated form of 71 kDa both of which labeled with a pentapeptidyl chloromethylketone 4 . The enzymatic properties of this preparation are indistinguishable from our previously described partially purified virus produced murine PC1 (24) . Enzymatically active murine PC2 was kindly provided by Dr. Iris Lindberg (Louisiana State University, New Orleans) and was purified from conditioned medium of Chinese hamster ovary PC2/7B2 expressing cells as described previously (25) .
Design of Quenched Fluorescent Substrates-Our previous studies (14) showed that a peptide (human pro-PTH(Ϫ6 to ϩ 7)) carboxylterminally extended relative to the cleavage site was cleaved more efficiently by furin than substrates comprising only the enzyme recognition site amino-terminal to the cleavage site. This implicated the importance of PЈ positions in influencing enzyme activity. Therefore, the quenched fluorescent substrates were designed following our previous study (23) with the Abz donor group NH 2 -terminal attached to position P 1 , and the Tyr(3-NO 2 ) acceptor group was placed at P 5 Ј sufficiently far from the cleavage site not to influence enzyme activity but not so far as to inordinately increase background fluorescence or reduce the intramolecular quenching effect (Fig. 1) . A serine residue was placed at the carboxyl terminus to aid peptide solubility. Table I shows the 12 quenched fluorogenic substrates prepared which comprise the natural human pro-PTH (QFS-3) and rat pro-PTHrP (QFS-14) sequences, together with 10 substituted sequences which were designed to test the importance of positions P 6 , P 5 , P 4 , P 3 , P 1 Ј, and P 2 Ј (QFS-4 to QFS-13). quenched fluorescent analogues (designated QFS-3 to QFS-14, see  Table I ), the fluorescent peptide, Abz-Lys-Ser-Val-Lys-Lys-Arg (designated FS-2), which represents the NH 2 -terminal portion preceding the cleavage site in human pro-PTH, as well as a peptide (designated S-10) comprising Lys-Ser-Val-Lys-Lys-Arg-Ser-Lys-Ser-Glu-Tyr-Ser, which is the sequence of QFS-10 without the fluorescent and quencher moieties, were synthesized in the Peptide Synthesis Facility of the Sheldon Biotechnology Center, McGill University, using a symphony automated synthesizer (Rainin, Woburn, MA) according to previously described procedures (23) . Following coupling of Fmoc-(3-nitro)-Tyr to preloaded H-Ser-4-hydroxymethylphenoxy resin, the peptide chain was elongated using Fmoc solid phase peptide chemistry until the final step when the Boc-anthranilic acid was added. The following side chain protecting groups were used: t-Boc for Lys, t-butyl for Ser and Asp, and 2,2,5,7,8-methylchroman-6-sulphonyl for Arg. Peptide derivatives were cleaved from the resin and deprotected by treatment with reagent K for 3 h (26), followed by lyophilization and repeated washing with ether.
Synthesis of Fluorescent and Other Peptidyl Substrates-All
Purification and Characterization of Fluorescent Substrates-The crude material from each synthesis was purified by reversed-phase high performance liquid chromatography (RP-HPLC), first using a semipreparative CSC-Exsil C 18 column (25 ϫ 0.94 cm, Chromatography Sciences Co., St-Laurent, Quebec, Canada) and then an identical type of analytical column (25 ϫ 0.46 cm). The buffer system comprised an aqueous 0.1% (v/v) CF 3 COOH solution and an organic phase of acetonitrile containing 0.1% (v/v) CF 3 COOH. Columns were eluted with a linear gradient from 5 to 60% organic phase in 60 min following a 5-min isocratic step at 5% organic phase; the flow rate was either 2.0 ml/min (semi-preparative) or 1.0 ml/min (analytical). The elution was monitored on-line by measurement of UV absorbance at 225 nm and the fluorescence at 420 nm after excitation at 320 nm in 1.0-ml fractions or on-line using a Varian Fluorichrom fluorescence detector. In the latter case, a combination of band filters (300 -380 nm) was used for excitation of the fluorophor, whereas a sharp cut-off filter (Ͼ400 nm) was used in the emission window. Each purified peptide analogue was characterized by ion spray mass spectrometry using an AP1 111 triple stage mass spectrometer (Sciex, Thornhill, Ontario, Canada) as reported (14) and by amino acid analysis. Amino acid analyses were performed following 18 -24 h hydrolysis in 5.7 N HCl at 110°C in vacuo using a modified Beckman 120C autoanalyzer equipped with a Varian DS604 integrator/plotter.
Enzymatic Assays-Aqueous stock solutions (0.5-1.5 mM) of quenched fluorescence peptidyl substrates were stored at Ϫ20°C. For enzymatic assay each substrate was incubated with the same amount of partially purified hfurin (4.9 M/h AMC released, determined using the fluorogenic substrate ϽGlu-Arg-Thr-Lys-Arg-MCA) in 50 mM sodium acetate, pH 7.0, 1.0 mM CaCl 2 in a total volume of 100 l. For murine PC1 the buffer used was 50 mM sodium acetate, pH 6.0, 10 mM CaC1 2 , whereas for murine PC2, it was 50 mM sodium acetate, pH 5.5, 5 mM CaCl 2 , and 0.1% Brij-30. Initial rate determinations were made in the presence of a range of peptidyl substrate concentrations (0.5-80 M) at 25°C in 96-well microtiter plates. Following addition of enzyme, the change in fluorescence was recorded with a Perkin-Elmer LS50B spectrofluorometer with a plate reader accessory using 320 and 420 nm as excitation and emission wavelength, respectively. The initial rate of cleavage (V 0 ) was determined with the built-in least square regression analysis system of the spectrofluorometer using the data recorded from 0 to 60 s after addition of the enzyme.
Correction for Quenching-The use of an extended sequence between the acceptor/donor pair can lead to significant background fluorescence as well as a decrease in the intramolecular quenching effect (23, 27) . Although this can be problematic in stopped-time assays, it can be circumvented by coupling RP-HPLC analysis to each time point to measure directly the amount of product released. When multiple samples are to be analyzed, this method is tedious, and the use of initial velocity measurement with increasing concentrations of substrate is preferred. However, our initial results with this procedure showed that, in addition to a decrease in intramolecular quenching, there is a significant contribution from intermolecular quenching both between two substrate molecules with increasing concentration but also between a substrate molecule and the released fluorescent product. Whereas the former is not significant for substrate concentrations less than 40 M, and the measured fluorescence is linear with respect to concentration of substrate (data not shown), the latter cannot be overlooked as the quenching appears rapidly. To correct for this, increasing amounts of the fluorescent NH 2 -terminal cleavage product, FS-2, were incubated in the presence and absence of a single representative substrate (both QFS-2 and QFS-4 were used with similar results) at pH 6.0 and pH 7.0. The decrease in fluorescence concomitant upon the increase in substrate concentration up to 40 M was thereby measured and used to correct the enzyme assay data. The change in fluorescence intensity per unit time was converted into M/h values using a calibration curve based upon the fluorescence of FS-2 and correction of the quenching effect of increasing amounts of substrate on the fluorescence of the released product. Determination of Inhibitor Constants-The inhibitory characteristics of compounds QFS-10 and QFS-12 were investigated using stoppedtime assays as well as initial rate assays as described above. Increasing amounts of peptide were mixed with a constant amount of hfurin in the presence of differing amounts of the fluorogenic substrate ϽGlu-ArgThr-Lys-Arg-MCA. Since these compounds could also quench the fluorescence produced by the released AMC, correction of the observed rate of cleavage was again required. 
according to the inhibitor mechanism outlined in the Appendix.
[S] and [I] denote the substrate and inhibitor concentration in M, respectively, V i and V max the rate of cleavage in M/h AMC released in the presence and in the absence of inhibitor, respectively, and K m , K i , and K i Ј denote the rate constants. The ability of peptide S-10 to inhibit cleavage of QFS-14 by hfurin was assessed. The K i value was determined either by using Dixon's representation at three substrate concentrations (7.5, 10, and 15 M) or by curve fitting of the data using the Enzfitter software to Equation 2.
In all cases, the velocity measurements were corrected for the quenching effect of increasing concentrations of QFS-14 on the release of the fluorescent product as described above.
RESULTS

Synthesis of the Quenched Fluorescent and Other Peptidyl
Substrates-The observed amino acid compositions of all purified quenched fluorescent peptidyl substrates as well as the S-10 peptide were consistent with expected values (data not shown). For all substrates, with one exception, the observed molecular weights obtained by mass spectrometry were within 2 mass units of that expected (data not shown). In the case of QFS-5, although the amino acid composition was consistent with expected values, the molecular weight was some 96 mass units higher than expected. Given that a methionine residue is at position P 3 , a likely explanation for the erroneous mass is that a side reaction yielding a trifluoroacetyl sulfonium salt occurred during final deprotection of the peptide.
Appropriate Cleavage of Quenched Fluorescent Peptidyl Substrates with Furin-All substrates were appropriately cleaved carboxyl-terminal to the (P 2 )Lys-(P 1 )Arg site. Fig. 2 shows a representative RP-HPLC chromatogram of the separation of digestion products of the substrate QFS-14 by hfurin. The substrate was cleaved at the expected site with production of the fluorescent NH 2 -terminal fragment Abz-Gly-Arg-Arg-LeuLys-Arg and the nonfluorescent but UV-absorbing COOH-terminal fragment Ala-Val-Ser-Glu-(3-nitro)-Tyr-Ser.
The PЈ-elongated substrates are very efficiently cleaved, and this favors the use of initial velocity measurements for analysis of kinetic data. As shown in Fig. 3 , more than 50% of the substrate (in this case 20 M QFS-7) was cleaved by hfurin within 4 min. Upon much longer incubation times (90 -1200 min) the presence of a guanidinoethyl mercaptosuccinic acidinhibitable carboxypeptidase activity which removes the COOH-terminal basic residue from the NH 2 -terminal fragment becomes apparent (Fig. 3, inset) . The presence of a similar minor carboxypeptidase activity, as yet uncharacterized, was observed previously in recombinant vaccinia virus PC1 preparations (23) .
Efficiency of Cleavage of Quenched Fluorescent Peptidyl Substrates with Furin-Representative plots of initial rate versus substrate concentration for substrates active with furin are shown in Fig. 4 , and the kinetic constants corrected for substrate quenching are summarized for all substrates in Table II .
Substitutions at P Positions-For several of the substrates, substitutions in the P positions were well tolerated with relative V max /K m values ranging from 0.3 for the "typical furin site" of rat pro-PTHrP (QFS-14) to 1.0 for the human pro-PTH sequence itself (QFS-3) to 1.5 for an "optimized" human pro-PTH furin site (QFS-8) (see Table II ). The sequence of the pro-PTH hexapeptide has been determined for several mammalian species (human, bovine, porcine, canine, rat, and mouse) and one avian (chicken) species. The choice of some of the QFS substitutions was guided by this knowledge. For example, although in mammalian species position P 3 is always occupied by Lys, in avians it is Met. Likewise, at position P 6 in all mammals Lys is present, and in avians Arg is substituted. Therefore, in QFS-4 Met substitutes for Lys at P 3 , and in QFS-5, additionally, Arg substitutes for Lys at P 6 . These substrates have V max and relative V max /K m values not dissimilar to those of human pro-PTH (QFS-3) itself. Substitution of the P 4 Val with Arg, as in QFS-7, did not modify the kinetic parameters significantly, whereas additional substitution of the P 6 Lys with Gly, as in QFS-8, to generate a sequence conforming to the "classical" furin site led to a 2-fold increase in V max .
One of the most deleterious substitutions was that of the P 6 Lys with Gly (QFS-6) emphasizing the critical role played by this residue in nonconsensus furin sites lacking a basic amino acid at P 4 . Both an increase in K m and decrease in V max was noted with this substitution (Table II) . Finally, whereas substitution of the P 3 Lys by a neutral amino acid (as in QFS -4) was well tolerated, furin cleavage was markedly compromised by substitution with Glu, an acidic amino acid. This was predominantly manifested by an increase in K m .
Substitutions in PЈ Positions-Examination of compilations of furin sites (29 -31) in proproteins reveals that P 1 Ј is often, although not always, a Ser residue as in human pro-PTH, and P 2 Ј is an aliphatic hydrophobic residue such as Val. We found that furin activity is very sensitive to substitution in PЈ positions. Substitution of P 2 Ј which is Val in both human pro-PTH (QFS-3) and rat pro-PTHrP (QFS-14) with Lys yielded a compound (QFS-10) that was not cleaved. Likewise, substitution of Val at P 1 Ј in conjunction with Ala at P 2 Ј again led to a non- FIG. 3 . Time course analysis of the cleavage of QFS-7 by recombinant hfurin. QFS-7 (20 M) was incubated for increasing times with recombinant hfurin at pH 7.0. Aliquots were taken at each time point, and the products were analyzed by RP-HPLC as described under "Experimental Procedures" and as shown in Fig. 2 . The main figure depicts the analysis up to 40 min, and the inset shows an extended analysis up to 20 h. QFS-7, Abz-Lys-Ser-Arg-Lys-Lys-Arg-Ser-Val-SerGlu-(NO 2 )-Tyr-Ser (q); the complete NH 2 -terminal fragment, Abz-LysSer-Arg-Lys-Lys-Arg (⅜); which, upon longer incubation times (inset) is transformed by an endogenous contaminating carboxypeptidase activity into its COOH-terminal truncated form, Abz-Lys-Ser-Arg-Lys-Lys (OE); COOH-terminal fragment, Ser-Val-Ser-Glu-(NO 2 )-Tyr-Ser (‚). cleaved compound (QFS-12). Replacement of Val at P 2 Ј with Ala yielded a substrate (QFS-11) that was cleaved but with a reduced V max , and substitution of P 1 Ј with Gly generated a substrate (QFS-13) with a V max that was reduced still further.
Efficiency of Cleavage of Quenched Fluorescent Peptidyl Substrates with PC1-Representative plots of initial rate versus
substrate concentration with murine PC1 are shown in Fig. 4 , and for all substrates the kinetic constants corrected for sub- Enzyme assays and data analysis were carried out as described under "Experimental Procedures." Note the difference in the scale of the y axes of the hfurin and murine PC1 plots. strate quenching are summarized in Table III . The best substrate for murine PC1, based upon the ratio V max /K m , was QFS-8 in which Gly substitutes for Lys at P 6 and Arg replaces Val at P 4 (Table III) . However, all other substrates (including QFS-6 and QFS-9 that were not well cleaved by hfurin), with the exception of QFS-10 and QFS-12, were reasonably well cleaved by murine PC1. In the case of QFS-10, the poor cleavage was due to an increased K m , whereas with QFS-12, both an increased K m and a decreased V max were noted (Table III) .
TABLE II Kinetic constants for cleavage of internally quenched fluorescent pro-PTH substrates with hfurin
Substrate Sequence K m V max V max /K m V max /K m relative k cat /K m ⌬(⌬G) b M M/h h Ϫ1 M Ϫ1 s Ϫ1 ϫ
QFS-10 and QFS-12
Are Inhibitors of Furin-As neither QFS-10 nor QFS-12 was cleaved by hfurin, we explored the possibility that they were inhibitors of furin. This was done by testing their ability to block hfurin activity on the ϽGlu-ArgThr-Lys-Arg-MCA fluorogenic substrate. The quenching of the AMC fluorescence in the presence of increasing concentrations of either compound was corrected as described for the QFS compounds. As shown in Fig. 5 , both compounds inhibited the cleavage of the fluorogenic substrate by hfurin at low micromolar concentrations. Additionally, both compounds functioned as mixed type inhibitors as an increase in K m values were concomitant with a decrease in observed V max (32) . This was confirmed by the reciprocal plot yielding straight lines intersecting the abscissa to the left of the 1/V axis. However, all replots, with the exception of the intercepts of the reciprocal plot versus [I], exhibited a strong parabolic character indicative of more than one molecule of inhibitor interacting with the enzyme (data not shown). From linear regression analysis of the intercept replots, K i Ј ϭ 21.9 ϩ 5.1 M (mean ϩ S.D.) for QFS-10 and 43.5 ϩ 1.0 M for QFS-12. A K i value could not be derived from this type of analysis due to the slope-parabolic nature of the slope replots. However, all kinetic constants could be derived from the equation in "Determination of Inhibitor Constants" under "Experimental Procedures" which was based upon the mechanism outlined in the Appendix. It can be deduced that the free enzyme (E) combines with the substrate (S) yielding the (ES) complex with K m ϭ 6.4 M and V max ϭ 10.9 M/h AMC released. However, the inhibitor (I) binds either ES to form a ternary complex IES or an EI complex to bind another molecule of inhibitor generating a second type of ternary complex (IEI). The type of ternary complex formed will depend upon whether the first molecule of inhibitor binds within the active site (EI) or elsewhere (IE). Both compounds appear to interact in an identical fashion with the active site region as both K i values are very similar being 5.7 and 4.6 M for QFS-10 and QFS-12, respectively (see Table IV) , and are also similar to the K m values obtained with the various QFS-peptidyl substrates (Table II). On the other hand, there is a 2-fold difference in K i Ј values for the two compounds, in agreement with the values obtained from linear regression analysis of the intercept replots, QFS-10 being the better of the two in binding to the alternate site. The ability of the QFS-10 nonfluorescent peptide sequence (S-10) to inhibit cleavage of a pro-PTHrP substrate (QFS-14) by hfurin is illustrated in Fig. 6 . The S-10 peptide behaves as a competitive inhibitor with a K i of 5.5 Ϯ 1.3 M (derived from the Dixon plot) or 5.9 Ϯ 0.3 M (obtained from curve fitting using the equation for competitive inhibition described under "Experimental Procedures").
TABLE III Kinetic constants for cleavage of internally quenched fluorescent pro-PTH substrates with mPCI
Substrate Sequence K m V max V max /K m V max /K m relative M M/h h Ϫ1 QFS-3 Abz-KSVKKR-SVSEYS 3.1 Ϯ 0
DISCUSSION
Chromogenic and fluorogenic substrates have been widely used in the study of proteolytic enzymes. Typically, the peptidyl portion of the enzyme recognition sequence is attached at the carboxyl terminus via the cleavage site to a chromophoric (e.g. 4-nitroaniline) or fluorophoric (e.g. aminomethylcoumarin) leaving group. The release of the chromophore which is monitored by increases in absorbance is an indicator of the enzyme activity. However, the presence of a bulky chromophoric group in the P 1 Ј position often leads to suboptimal enzyme activity. In addition, these substrates lack amino acids on the PЈ side of the scissile bond which may be critical for optimal enzyme activity. For these reasons a longer substrate which extends into the PЈ positions is desirable (23, 33, 34) . Although a nonfluorogenic peptide can be used, the derivation of kinetic parameters requires separation and quantitation of the cleavage products by RP-HPLC. This can become tedious when a series of peptidyl substrates is to be analyzed, and in this respect the quenched fluorescent substrate approach (23, 33) has distinct advantages.
We previously showed that both furin and PC1 can correctly cleave a tridecapeptide spanning the pro-PTH cleavage site (14, 24) but that furin was much more efficient (14) . This has been confirmed in the present study with the equivalent pro-PTH quenched fluorescent substrate. The pro-PTHrP cleavage site (Arg-Arg-Leu-Lys-Arg (P 5 -P 1 )), which conforms to the typical furin site, has not been examined previously by the direct cleavage method. In this study, we demonstrated first that a pro-PTHrP-quenched fluorescent peptide substrate was appropriately cleaved at the bond carboxyl-terminal to Lys(P 2 )-Arg(P 1 ). We then showed that, as with pro-PTH, furin was more efficient than PC1 in performing this cleavage. Unlike pro-PTH which is expressed almost exclusively in the endocrine cells of the parathyroid gland, pro-PTHrP is widely expressed in a variety of cell types of nonendocrine as well as neuroendocrine origin, and it might therefore be anticipated that the ubiquitously expressed furin or a related furin-like enzyme would be the convertase responsible for releasing PTHrP from pro-PTHrP rather than PC1 or PC2 which are expressed exclusively in endocrine and neuroendocrine cells. It has previously been shown that production of biologically active PTHrP can be inhibited by antisense furin RNA technology (22, 35) , although it remains uncertain from those studies whether the processing of pro-PTHrP is due directly to furin or a different convertase which requires prior activation by furin. Importantly, we show here for the first time the direct action of furin in efficiently cleaving the pro-PTHrP substrate at the appropriate site. Introduction of antisense furin RNA into a hypercalcemia of malignancy associated tumor cell line led to a negative effect on tumor cell volume in vivo and positive effect on animal survival time (35) . Thus development of potent inhibitors targeted to the furin site of pro-PTHrP may be of significant anti-neoplastic benefit. The studies described here point the way to the design of a new generation of inhibitors that will block pro-PTHrP cleavage.
Previous studies have demonstrated the critical role played by the basic amino acids at positions P 2 and P 1 of the proprotein convertase recognition site. In the present study further insights were gained into what constitutes a competent furin site by focusing on changes at positions P 6 -P 3 , P 1 Ј, and P 2 Ј. Several changes from the human pro-PTH sequence were well tolerated in the P 6 -P 3 positions. However, furin cleavage was compromised by substitution of Glu for Lys at P 3 leading to a decreased affinity, whereas V max remained unchanged. This may well be due to unfavorable interactions with the acidic residues postulated to form part of the binding pocket of furin which contacts the P 3 substrate residue (36 -38) . This could also explain for QFS-9 the large increase in relative transition state binding energy (⌬(⌬G) (28) of 1.7 kcal/mol resulting in a combined effect on recognition and cleavage. The P 6 Lys plays a critical role in nonconsensus furin sites such as that found in human pro-PTH which lack a basic amino acid at P 4 . Substi- Mean value 4.6 Ϯ 0. tution of Gly for Lys at position P 6 reduced specificity for furin both by an increased K m and V max , whereas specificity for PC1 increased primarily through an altered V max . This deleterious effect of removing the basic amino acid at P 6 could be compensated for by converting P 4 from Val to Arg thereby creating a consensus furin site.
Importantly, we show that furin and PC1 activities are very sensitive to certain substitutions in the PЈ positions. This result was to be anticipated by previous studies showing poor cleavage of peptidyl substrates having non-natural and bulky residues at the P 1 Ј position (39, 40) and those using small fluorogenic peptidyl-MCA substrates which indicated that the efficiency of cleavage depends more on the deacylation step than on the recognition step (21) . For example, in the present studies, substitution of the P 1 Ј Ser with Gly led to a substrate that was cleaved much less well, predominantly due to a reduced V max . Strikingly, substitution of the P 1 Ј Ser with Val in combination with replacement of the P 2 Ј Val with Ala as well as the single substitution of the P 2 ЈVal with Lys generated compounds that were not cleaved at all by furin and, additionally, were poorly cleaved by PC1. Interestingly, substitution in the proalbumin sequence of the P1Ј Asp by Lys was found to completely abolish the removal of the propeptide by furin (20) . Together with the present data, this implies that, for a proper furin cleavage, positions P1Ј and P2Ј should not be both occupied by a positively charged Lys residue or a hydrophobic aliphatic residue. In the present studies, further analysis established the inhibitory nature of the QFS-10 and QFS-12 compounds on furin activity. Both these compounds are specific inhibitors of furin, whereas they are cleaved by murine PC1 (Table III) at a rate of 9.5 and 1.6 M/h, respectively, and QFS-10 is cleaved by murine PC2 at a rate of 0.81 M/h when using a concentration of 20 M. However, with furin these two substrates behave as mixed type competitive inhibitors (see Appendix, Fig. 9 ) and bind at two sites on the enzyme, one of which we hypothesize to be the substrate pocket itself and the other of unknown location. This is the first example of (i) a peptidyl inhibitor that is apparently specific for furin, and (ii) an inhibitor for the proprotein convertases that binds at two sites on such enzymes. Concerning the first point, it should be noted that, for all the potential proprotein P 2 Ј Lys-containing substrates, none appears to be a substrate for furin. The list of such proteins includes the pro-Mü llerian inhibiting substance, proneurokinin A, propancreatic polypeptide, and proprotein tyrosine phosphatase-receptor. Both pro-Mü llerian inhibiting substance and proprotein tyrosine phosphatase-receptor are cleaved by PC5 (41, 42) , and propancreatic polypeptide is processed in the regulated secretory pathway by the neuroendocrine-specific enzymes, PC1 and PC2 (43) . As far as the second point is The rate of release of the NH 2 -terminal fluorescent product by hfurin at pH 7.0 was measured by an on-line assay as described under "Experimental Procedures." The observed fluorescence was converted to M/h units using a calibration curve based on the fluorescence of the FS-2 peptide as described in the text and shown in Fig. 7 . ࡗ, raw data; q, data corrected for the substrate quenching effect. Nonlinear regression analysis of the data from 0.5 to 20 M QFS-8 for the best hyperbola yielded the curve (E) that was used for determination of the K m and V max .
FIG. 9. Schema of mixed type inhibition of enzyme activity.
The free enzyme (E) combines with the substrate yielding the (ES) complex. The inhibitor binds either (ES) to form a ternary complex (IES) or an EI complex able to bind another molecule of inhibitor generating a second type of ternary complex (IEI). The type of ternary complex formed will depend upon whether the first molecule of inhibitor binds within the active site (EI) or elsewhere (EI). The equation describing this model that was used to compute K i and K i Ј is under "Experimental Procedures." concerned, it is very unlikely that the substrate binding site would be able to accommodate two dodecapeptide inhibitor molecules simultaneously. Little is known about sites on convertases that bind other molecules as modulators of enzymatic activity with the exception of the neuroendocrine protein 7B2 and PC2 (44 -46) . This interaction is thought to involve the COOH-terminal inhibitory region of 7B2 acting within the active site of the enzyme and a second site comprising a proline-rich and ␣-helical region of the 7B2 molecule (47) . We therefore propose that the sequence Arg-Xaa-(Lys/Arg)-ArgSer-Lys (P 4 -P 2 Ј) could serve as the basis for designing further furin-specific inhibitors. We have already demonstrated in the present study that one such peptide, S-10, can inhibit furin cleavage of a pro-PTHrP substrate in a competitive fashion in the low micromolar range. In addition, in future studies it will be important to elucidate the nature of the secondary site targeted by some of these inhibitors. This will aid in improving inhibitor design even further.
